Table 1.
Demographic Characteristics for Participants With Acute Human Immunodeficiency Virus (HIV) Infection (AHI), Overall and for Those With Complete Case Analyses, and HIV-Uninfected Healthy Controls
| AHI Group | |||
|---|---|---|---|
| Characteristic | Control Group | Overall | Complete Casesa |
| Age, y | 26.5 (23–32)b | 28.0 (23–32)b | 32.5 (27.5–39) |
| Male sex, % | 95.9b | 89.8b | 50.0 |
| Estimated infection duration, d | 17 (13–23) | 15 (11–19) | … |
| Time from diagnosis to ART initiation, d | 1 (0–2)c | 2 (2–3) | … |
| Fiebig stage I/II, % | 43.0 | 45.8 | … |
| HIV subtype CRF01_AE, % | 82.2 | 83.7 | … |
| Plasma HIV RNA load, log10 copies/mLd | 5.75 (5.24–6.56) | 5.55 (4.89–6.34) | … |
| CSF HIV RNA load, log10 copies/mLd | 3.36 (2.34–4.32) | 3.37 (2.74–4.07) | … |
| CD4+ T cell count, cells/mm3,d | 387 (293–506) | 392 (311–555) | … |
| CD8+ T cell count, cells/mm3,d | 512 (306–928) | 472 (304–728) | … |
| CD4+ to CD8+ T-cell ratiod | 0.80 (0.45–1.17) | 0.86 (0.53–1.38) | … |
Data are median values (interquartile ranges), unless otherwise indicated.
aDefined as participants with AHI who had samples available from all time points.
bStatistically significantly different from the value for the control group.
cStatistically significantly different from the value for the complete case group.
dAt baseline.